Comparison of Supervised and Unsupervised Physical Activity Programs During a Weight Loss Intervention for Adults
NCT ID: NCT02693132
Last Updated: 2018-11-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2016-02-29
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
NCT01537796
Evaluation of Alternative Exercise Treatments on Weight Loss in Overweight Women.
NCT00177632
Feasibility of a Campaign Intervention Compared to a Standard Behavioral Weight Loss Intervention in Overweight and Obese Adults
NCT01803737
Enhancing Exercise Participation in Overweight Adults
NCT00177476
Physical Activity Following Surgery Induced Weight Loss
NCT00692367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be randomized to one of three groups: supervised physical activity prescribed in min/week (SUP-PA), unsupervised physical activity prescribed in min/week (UNSUP-PA), and unsupervised physical activity prescribed in steps/day (STEP). Participants in all three groups will participate in a behavioral weight loss intervention which includes dietary counseling and weekly group sessions during the 12-week program. SUP-PA will be prescribed 150 minutes/week of moderate-to-vigorous physical activity (MVPA) completed under direct supervision of trained staff at a designated health-fitness facility. UNSUP-PA will be prescribed a physical activity dose matched to SUP-PA. STEP will be prescribed a 10,000 step/day recommendation with 2,500 of those steps completed at a "brisk" pace. The primary aim of this study is to compare the effects of all three groups on moderate-to-vigorous physical activity (MVPA) accumulated in bouts of at least 10 minutes. The primary outcome will be assessed at baseline, week 4, week 8, and week 12. Secondary aims of this trial include comparing light intensity physical activity, sedentary time, cardiorespiratory fitness, weight, body composition, waist circumference measures, physical activity self-efficacy, blood pressure, and dietary intake across all three groups. Secondary aims will be assessed at baseline and week 12.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supervised (SUP-PA)
Weight loss intervention that focuses on supervised physical activity and involves an energy restricted diet. Physical activity will be supervised by trained staff.
Supervised (SUP-PA)
Weight loss intervention that involves an energy restricted diet plus the inclusion of 150 minutes per week of supervised moderate-to-vigorous intensity physical activity.
Unsupervised (UNSUP-PA)
Weight loss intervention that focuses on unsupervised physical activity (identical dose to SUP-PA) and involves an energy restricted diet (identical diet to SUP-PA). Physical activity will be self-monitored but no activity tracker will be used as an intervention tool.
Unsupervised (UNSUP-PA)
Weight loss intervention that involves an energy restricted diet plus the inclusion of 150 minutes per week of unsupervised moderate-to-vigorous intensity physical activity.
Step-based (STEP)
Weight loss intervention that focuses on unsupervised physical activity prescribed as steps/day and involves an energy restricted diet (identical diet to SUP-PA and UNSUP-PA). Physical activity will be self-monitored and a pedometer will be used to track steps/day.
Step-based (STEP)
Weight loss intervention that involves an energy restricted diet plus the inclusion of physical activity in the form of 10,000 steps/day with 2,500 "brisk" steps/day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supervised (SUP-PA)
Weight loss intervention that involves an energy restricted diet plus the inclusion of 150 minutes per week of supervised moderate-to-vigorous intensity physical activity.
Unsupervised (UNSUP-PA)
Weight loss intervention that involves an energy restricted diet plus the inclusion of 150 minutes per week of unsupervised moderate-to-vigorous intensity physical activity.
Step-based (STEP)
Weight loss intervention that involves an energy restricted diet plus the inclusion of physical activity in the form of 10,000 steps/day with 2,500 "brisk" steps/day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-55 years old
* BMI of 25.0 to \<40.0 kg/m2
* Ability to provide informed consent
* Ability to provide physician's clearance to participate in a weight loss intervention
Exclusion Criteria
* Presence of contraindications to physical activity as identified on a physical activity readiness questionnaire (PAR-Q)
* History of metabolic, cardiac, or pulmonary disease that classifies the individual as high risk by the American College of Sports Medicine (e.g., coronary heart disease, diabetes mellitus, uncontrolled hypertension, etc.)
* History of myocardial infarction, coronary bypass surgery, angioplasty, or other cardiovascular- related surgeries.
* Taking medication that may affect heart rate or blood pressure responses to physical activity
* Resting systolic blood pressure ≥150mmHg or diastolic blood pressure ≥100mmHg.
* Medication that may affect body weight/metabolism (e.g., synthroid).
* Current or previous participation in a physical activity or weight management research project in the past 6 months
* Weight loss of ≥5% or 15 pounds total of current body weight in the previous 6 months.
* Currently being treated for an eating disorder (e.g., anorexia, bulimia, etc.)
* Previously undergone bariatric surgery (e.g., lap-band, gastric bypass, etc.)
* For women, those currently pregnant, pregnant during the previous 6 months, or plan on becoming pregnant in the next 6 months
* Currently being treated for any psychological issues or problems, taking any psychotropic medications, or receiving treatment with psychotropic medications within the previous 6 months.
* Being out of town during for an extended amount of time during the weight loss intervention which may affect participation in the study
* Currently using a physical activity monitor to track activity (e.g., Jawbone UP, Fitbit, etc.)
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John M. Jakicic, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seth A Creasy
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
John M Jakicic
Role: STUDY_CHAIR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Physical Activity and Weight Management Research Center
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO15110570
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.